Safety and efficacy of a xenogeneic DNA vaccine encoding for human tyrosinase as adjunctive treatment for oral malignant melanoma in dogs following surgical excision of the primary tumor - Concepedia

Concepedia

Publication | Open Access

Safety and efficacy of a xenogeneic DNA vaccine encoding for human tyrosinase as adjunctive treatment for oral malignant melanoma in dogs following surgical excision of the primary tumor

DOI Full Paper Access

218

Citations

20

References

2011

Year

Deborah A. Grosenbaugh, A. Timothy Leard, Philip J. Bergman, Mary K. Klein, Karri A. Meleo, Steven Susaneck, Paul R. Hess, Monika K. Jankowski, Pamela D. Jones, Nicole F. Leibman,

American Journal of Veterinary Research

Abstract

Response to DNA vaccination in dogs with oral MM may be useful in development of plasmid DNA vaccination protocols for human patients with similar disease.

References

	Year	Citations
Multi-center, Placebo-controlled, Double-blind, Randomized Study of Oral Toceranib Phosphate (SU11654), a Receptor Tyrosine Kinase Inhibitor, for the Treatment of Dogs with Recurrent (Either Local or Distant) Mast Cell Tumor Following Surgical Excision Cheryl A. London, Phyllis B. Malpas, Stacey L. Wood-Follis, Clinical Cancer Research	2009	416
Long-term survival of dogs with advanced malignant melanoma after DNA vaccination with xenogeneic human tyrosinase: a phase I trial. Philip J. Bergman, J. A. McKnight, Andrew Novosad, PubMed	2003	331
Development of a xenogeneic DNA vaccine program for canine malignant melanoma at the Animal Medical Center Philip J. Bergman, M. A. Camps‐Palau, J. A. McKnight, Vaccine VaccinationVeterinary VaccineXenotransplantationVaccine DevelopmentVaccine Research	2005	291
Coupling and Uncoupling of Tumor Immunity and Autoimmunity Wilbur B. Bowne, Roopa Srinivasan, Jedd D. Wolchok, The Journal of Experimental Medicine	1999	241
Tumor immunity and autoimmunity induced by immunization with homologous DNA. L W Weber, Wilbur B. Bowne, Jedd D. Wolchok, Journal of Clinical Investigation HistocompatibilityDifferentiation AntigensImmunologyImmunoeditingAntigen Processing	1998	229
A RETROSPECTIVE ANALYSIS OF 140 DOGS WITH ORAL MELANOMA TREATED WITH EXTERNAL BEAM RADIATION David R. Proulx, David Ruslander, Richard K. Dodge, Veterinary Radiology & Ultrasound Adaptive RadiotherapyOptimal Fractionation SchemeRadiation MedicineRadiation TherapyMedicine	2003	171
Use of carboplatin for treatment of dogs with malignant melanoma: 27 cases (1989–2000) Kenneth M. Rassnick, David Ruslander, Susan M. Cotter, Journal of the American Veterinary Medical Association	2001	153
Prognosis after Surgical Excision of Canine Melanomas D. E. Bostock Veterinary Pathology Surgical OncologyPathologySurgeryDermatologyOncology	1979	142
Canine Oral Melanoma: Comparison of Surgery Versus Surgery Plus Corynebacterium parvum E. Gregory MacEwen, A. K. Patnaik, Hugh Harvey, Cancer Investigation	1986	136
Evaluation of cisplatin combined with piroxicam for the treatment of oral malignant melanoma and oral squamous cell carcinoma in dogs Pedro A. Boria, Daryl J. Murry, Peter Bennett, Journal of the American Veterinary Medical Association	2004	134

Page 1